Phathom Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 12.47 M | $135.26 M | 0.00% | 14.89% |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 08/04/2026 | 7.46 M | $80.99 M | 0.00% | 8.91% |
| BLACKROCK, INC. | 08/07/2026 | 4.53 M | $49.10 M | 11.40% | 5.40% |
| INVESCO LTD. | 08/14/2026 | 4.03 M | $43.72 M | -6.76% | 4.81% |
| CARLYLE GROUP INC. | 08/07/2026 | 3.50 M | $37.94 M | 0.00% | 4.18% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 3.38 M | $36.63 M | -16.08% | 4.03% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.66 M | $28.83 M | 2.84% | 3.17% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2026 | 2.17 M | $23.51 M | 52.48% | 2.59% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 1.97 M | $21.38 M | 98.17% | 2.35% |
| NEA MANAGEMENT COMPANY, LLC | 08/14/2026 | 1.96 M | $21.27 M | 0.00% | 2.34% |
| 683 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.85 M | $20.07 M | 0.00% | 2.21% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.78 M | $19.29 M | 183.94% | 2.12% |
| STATE STREET CORP | 08/07/2026 | 1.59 M | $17.21 M | 14.38% | 1.89% |
| CATALYS PACIFIC, LLC | 08/05/2026 | 1.49 M | $16.21 M | 0.00% | 1.78% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 08/14/2026 | 1.46 M | $15.87 M | 21.35% | 1.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.32 M | $14.28 M | -0.93% | 1.57% |
| WASATCH ADVISORS LP | 07/10/2026 | 1.31 M | $14.18 M | -2.51% | 1.56% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 1.05 M | $11.41 M | -35.38% | 1.26% |
| PROPEL BIO MANAGEMENT, LLC | 08/13/2026 | 1.05 M | $11.40 M | 24.85% | 1.25% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 1.02 M | $11.09 M | 100.00% | 1.22% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 796.63 K | $8.64 M | 19.61% | 0.95% |
| SUMMITTX CAPITAL, L.P. | 08/14/2026 | 789.55 K | $8.57 M | -20.72% | 0.94% |
| HSBC HOLDINGS PLC | 08/14/2026 | 709.70 K | $7.70 M | 100.00% | 0.85% |
| MARSHALL WACE, LLP | 08/13/2026 | 666.09 K | $7.23 M | -22.61% | 0.80% |
| ECOR1 CAPITAL, LLC | 08/14/2026 | 625.00 K | $6.78 M | 0.00% | 0.75% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 532.00 K | $5.77 M | -42.49% | 0.64% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 519.08 K | $5.63 M | 7.66% | 0.62% |
| CITADEL ADVISORS LLC | 09/02/2026 | 480.80 K | $5.22 M | -6.80% | 0.57% |
| NORTHERN TRUST CORP | 08/13/2026 | 458.30 K | $4.97 M | 10.45% | 0.55% |
| STEPSTONE GROUP LP | 08/13/2026 | 422.09 K | $4.58 M | 0.00% | 0.50% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 419.09 K | $4.55 M | 2.46% | 0.50% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 419.09 K | $4.55 M | 100.00% | 0.50% |
| WOODLINE PARTNERS LP | 08/14/2026 | 369.05 K | $4.00 M | 0.00% | 0.44% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 354.57 K | $3.85 M | 4.68% | 0.42% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 07/08/2026 | 327.28 K | $3.55 M | 124.27% | 0.39% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 293.98 K | $3.19 M | 15.64% | 0.35% |
| JPMORGAN CHASE & CO | 08/12/2026 | 275.25 K | $2.99 M | -4.24% | 0.33% |
| SIMPLIFY ASSET MANAGEMENT INC. | 07/16/2026 | 249.27 K | $2.70 M | -5.00% | 0.30% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 226.40 K | $2.46 M | -25.96% | 0.27% |
| JANE STREET GROUP, LLC | 08/14/2026 | 212.71 K | $2.31 M | 100.00% | 0.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 210.30 K | $2.28 M | -35.05% | 0.25% |
| UBS GROUP AG | 08/13/2026 | 204.57 K | $2.22 M | -43.23% | 0.24% |
| NEWEDGE ADVISORS, LLC | 08/12/2026 | 203.96 K | $2.21 M | 11.45% | 0.24% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2026 | 200.00 K | $2.17 M | -19.80% | 0.24% |
| MORGAN STANLEY | 08/13/2026 | 199.91 K | $2.17 M | 160.70% | 0.24% |
| JUMP FINANCIAL, LLC | 08/13/2026 | 191.87 K | $2.08 M | 625.53% | 0.23% |
| OPALEYE MANAGEMENT INC. | 08/14/2026 | 185.59 K | $2.01 M | 100.00% | 0.22% |
| CITADEL ADVISORS LLC | 09/02/2026 | 184.90 K | $2.01 M | -51.73% | 0.22% |
| TREXQUANT INVESTMENT LP | 08/14/2026 | 173.88 K | $1.89 M | -40.72% | 0.21% |
| JONES HILL CAPITAL LP | 08/13/2026 | 161.49 K | $1.75 M | 100.00% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Phathom Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 221 institutional investors and hedge funds held shares of Phathom Pharmaceuticals Inc. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 12.47 M
Medicxi Ventures Management (Jersey) Ltd: 7.46 M
BlackRock, Inc.: 4.53 M
Invesco Ltd.: 4.03 M
Carlyle Group Inc.: 3.5 M
MILLENNIUM MANAGEMENT LLC: 3.38 M
86.56% of Phathom Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 82.72 M shares in the last 24 months. This purchase volume represents approximately $919.01 M in transactions.